Nicholas Samaras
Vorsitzender bei GENETIC SIGNATURES LIMITED
Ursprung des Netzwerks ersten Grades von Nicholas Samaras
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Miscellaneous Commercial Services | 18 | |
MuriGen Pty Ltd.
MuriGen Pty Ltd. Pharmaceuticals: MajorHealth Technology MuriGen Pty Ltd. discovers, develops and commercializes drugs. It develops drugs for cancer, arthritis, thrombocytopenia, inflammatory diseases, epilepsy and thalassemia. The company was founded by Douglas James Hilton on September 28, 1999 and is headquartered in Melbourne, Australia.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Nicholas Samaras
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Cytyc Corp.
Cytyc Corp. Medical SpecialtiesHealth Technology Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA. | Medical Specialties | Corporate Officer/Principal | |
NEOGENOMICS, INC. | Medical/Nursing Services | Director/Board Member | |
SIRTEX MEDICAL LIMITED | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO | |
IMMUTEP LIMITED | Biotechnology | Director of Finance/CFO | |
Nottingham Trent University | College/University | Undergraduate Degree | |
Cellestis Pty Ltd.
Cellestis Pty Ltd. BiotechnologyHealth Technology Cellestis Ltd. develops, manufactures and markets medical diagnostic products. It develops and markets QuantiFERON technology products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune responses of T cell lymphocytes using whole blood samples. Its product portfolio includes QuantiFERON-CMI kit, an in vitro laboratory test for the measurement of cell mediated immune responses in humans using whole blood, QuantiFERON-TB Gold, an in vitro diagnostic test for the detection of mycobacterium tuberculosis infection. The company was founded in 2000 and is headquartered in Chadstone, Australia. | Biotechnology | Founder | |
University of London | College/University | Doctorate Degree | |
The University of New South Wales | College/University | Undergraduate Degree Graduate Degree | |
Macquarie University | College/University | Undergraduate Degree | |
The University of Sydney | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
University of Portsmouth | College/University | Doctorate Degree | |
ONCOSIL MEDICAL LIMITED | Medical Specialties | Director of Finance/CFO | |
University of Technology Sydney | College/University | Undergraduate Degree Undergraduate Degree | |
University of Western Sydney | College/University | Undergraduate Degree | |
Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
CPA Australia Ltd.
CPA Australia Ltd. Miscellaneous Commercial ServicesCommercial Services CPA Australia Ltd. is an Australian company that has been operating since 1954 and provides education, training, technical support, and advocacy services in the accounting profession. The private company is based in Southbank, Australia and has subsidiaries in Hong Kong. The company engages with governments, regulators, and industries to advocate for policies that stimulate sustainable economic growth. With over 166,000 members working in 100 countries and regions, CPA Australia is one of the world's largest accounting bodies. It was founded in 1886 by Andrew Lyell, Arthur Cleveland, Benjamin Doughty Smith, Thomas Brentnall, John McAlister Howden, Charles Morell Holmes, William Crellin, and Edward Langton. Andrew Paul Hunter has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Novartis Vaccines & Diagnostics SL | Corporate Officer/Principal | ||
Columbus University | College/University | Masters Business Admin | |
APAF Ltd.
APAF Ltd. Miscellaneous Commercial ServicesCommercial Services APAF Ltd. provides proteomic services. The non-profit company is based in Sydney, Australia. | Miscellaneous Commercial Services | Chairman | |
Biological Dynamics, Inc.
Biological Dynamics, Inc. Medical DistributorsDistribution Services Biological Dynamics, Inc. engages in the development of cancer diagnostic solutions for labs and homes. Its platform offers a way to isolate cell-free nanoparticles and macromolecules directly from whole blood, serum, or plasma. The firm also develops a suite of oncology tests for early cancer detection, treatment response, and recurrence monitoring. The company was founded by Raj Krishnan, Edward D. Truitt III, Michael J. Heller, Roy Lefkowitz, and David Charlot in 2008 and is headquartered in San Diego, CA. | Medical Distributors | Chief Operating Officer | |
BLIGH RESOURCES LTD | Precious Metals | Corporate Secretary | |
The CEO Institute (Australia) | Chairman | ||
Rarecells USA, Inc.
Rarecells USA, Inc. Packaged SoftwareTechnology Services Rarecells USA, Inc. is a company dedicated to early cancer detection to save lives. The company is based in New York, NY. The company believes that accurate and early cancer detection has the potential to save millions of lives. Rarecells is developing a prostate cancer test and a multi-cancer test for early cancer diagnosis. The company is currently conducting three clinical studies to evaluate the performance of their dedicated iset-based assay. The company was founded in 2011 by Patrizia Paterlini-Bréchot, who has been the CEO since 2011. | Packaged Software | Director/Board Member | |
Harvard Business School | College/University | Graduate Degree | |
Governance Institute of Australia Ltd.
Governance Institute of Australia Ltd. Miscellaneous Commercial ServicesCommercial Services Governance Institute of Australia Ltd. provides education, support, and networking opportunities for directors, Australian company secretaries, governance advisers, and risk managers. The private company is based in Sydney, Australia. Megan Motto has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Beckman Coulter Australia Pty Ltd.
Beckman Coulter Australia Pty Ltd. Medical SpecialtiesHealth Technology Part of Danaher Corp., Beckman Coulter Australia Pty Ltd. is an Australian company that manufactures and distributes clinical laboratory equipment. The company is based in Gladesville, Australia. | Medical Specialties | Chief Executive Officer | |
Prospection Pty Ltd.
Prospection Pty Ltd. Packaged SoftwareTechnology Services Prospection Pty Ltd. engages in the provision of a software as a service based analytics platforms. Its products and services include PharmDash, PharmMap, and Prospection Labs. The company was founded by Eric Chung, Ricky Chen, and Peter Cronin in 2012 and is headquartered in Haymarket, Australia. | Packaged Software | Chairman | |
AQUS ENTE | Hotels/Resorts/Cruise lines | Corporate Secretary | |
VITACO HOLDINGS LTD | Pharmaceuticals: Other | Corporate Secretary | |
Kinetic Diagnostics, Inc.
Kinetic Diagnostics, Inc. Medical SpecialtiesHealth Technology Kinetic Diagnostics, Inc. provides precision medicine for athletes and fitness. The company was founded by James Valentine and Trisha Brown and is headquartered in Berkeley, CA. | Medical Specialties | Chief Executive Officer | |
KYCKR LIMITED | Financial Publishing/Services | Director of Finance/CFO | |
IDbyDNA, Inc.
IDbyDNA, Inc. BiotechnologyHealth Technology IDbyDNA, Inc. operates as a precision medicine company that focuses on metagenomic approaches for infectious disease identification. It develops technologies to enable universal microorganism detection. The firm help doctors and scientists to detect any pathogen in any sample, thereby removing barriers for the adoption of metagenomics in clinical settings, ultimately leading to faster public health responses during infectious disease outbreaks. The company was founded by Martin G. Reese, Guochun Liao, Mark Yandell, and Robert Schlaberg in Noveber 2014 and is headquartered in San Mateo, CA. | Biotechnology | Chief Executive Officer | |
ASSOCIATE GLOBAL PARTNERS LIMITED | Investment Managers | Director of Finance/CFO | |
LITIGATION CAPITAL MGMT. | Miscellaneous Commercial Services | Corporate Secretary | |
WCM GLOBAL GROWTH LIMITED | Investment Trusts/Mutual Funds | Corporate Secretary | |
Alveo Technologies, Inc.
Alveo Technologies, Inc. Medical SpecialtiesHealth Technology Alveo Technologies, Inc. operates a pre-clinical stage medical diagnostics company that creates infectious disease diagnostic devices. The company was founded by Ron Chiarello, Michael A. Aicher, Lawrence M. Blatt and Sumita Pennathur in 2014 and is headquartered in Alameda, CA. | Medical Specialties | Founder Director/Board Member | |
Roswell Biotechnologies, Inc.
Roswell Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Roswell Biotechnologies, Inc. is a company that is digitizing biology with molecular electronics to diagnose and treat diseases. The company has developed the world's first molecular electronics chip, the Roswell ME Chip™, which reads all molecules of life and provides direct real-time electrical detection of single-molecule events on-chip. The company's platform technology reduces the cost and complexity of DNA sequencing to address large markets in infectious disease surveillance and containment, precision medicine, molecular diagnostics, and DNA digital data storage. Roswell Biotechnologies was founded in 2014 by leaders in DNA sequencing and is headquartered in San Diego, CA. The company was founded by Mola Paul and Barry Merriman, with Mola Paul serving as the CEO since 2014. | Miscellaneous Commercial Services | Chairman | |
Techcyte, Inc.
Techcyte, Inc. Packaged SoftwareTechnology Services Techcyte, Inc. is a world leader in AI-based digital diagnostics for lab medicine. The company is based in Orem, UT and was founded in 2013 by Ralph Yarro and Mohamed E. Salama. Techcyte's clinical pathology AI platform uses deep machine learning to perform automated analysis of whole slide microscopy images, revolutionizing digital diagnostics for human, animal, and environmental clinics and labs. Techcyte's clinical pathology platform is for research use only in some locations. The company provides an AI software platform for clinical pathology that leverages machine learning for quicker, more efficient diagnoses for laboratories and patients. Ralph Yarro has been the CEO since 2013. | Packaged Software | Director/Board Member | |
Roche Sequencing Solutions, Inc.
Roche Sequencing Solutions, Inc. Medical/Nursing ServicesHealth Services Roche Sequencing Solutions, Inc. engages in providing personalized healthcare by creating diagnostics and treatments tailored to individual genetic and disease profiles. The firm's solutions include NGS Oncology Assays, sample collection, nucleic acid extraction and library preparation. The company is headquartered in Pleasanton, CA. | Medical/Nursing Services | President | |
BOOKTOPIA GROUP LIMITED | Specialty Stores | Corporate Secretary | |
Brainmates Pty Ltd. | Chairman | ||
Rarecells Diagnostics SAS
Rarecells Diagnostics SAS Packaged SoftwareTechnology Services Rarecells Diagnostics SAS is a French company passionate about saving lives by detecting and eliminating cancer at its start. The company is based in Paris, France and was founded by Patrizia Paterlini-Bréchot, who has been the CEO since incorporation. The company believes that accurate, early cancer detection has the potential to save millions of lives. Rarecells Diagnostics has developed the ISET blood filtration technology, which enables cell culture to generate xenograph of avatars. The company is currently conducting three clinical studies to evaluate the performance of their dedicated ISET-based assay to allow early detection of prostate cancer. The company is also developing a multi-cancer test for early cancer diagnosis and is working with researchers to propel care forward. | Packaged Software | Director/Board Member | |
The Institute of Chartered Accountants in Australia | Corporate Officer/Principal | ||
ENERGY ACTION LIMITED | Miscellaneous Commercial Services | Corporate Secretary | |
Chartered Accountants Australia & New Zealand
Chartered Accountants Australia & New Zealand Miscellaneous Commercial ServicesCommercial Services Chartered Accountants Australia & New Zealand is an association for chartered accountants that provides accounting services. The non-profit company is based in Auckland, New Zealand. | Miscellaneous Commercial Services | Corporate Officer/Principal |
Statistik
International
Australien | 31 |
Vereinigte Staaten | 15 |
Vereinigtes Königreich | 4 |
Spanien | 2 |
Frankreich | 2 |
Sektoral
Consumer Services | 12 |
Health Technology | 10 |
Commercial Services | 10 |
Health Services | 5 |
Technology Services | 5 |
Operativ
Director/Board Member | 43 |
Corporate Officer/Principal | 22 |
Corporate Secretary | 19 |
Director of Finance/CFO | 13 |
Chairman | 11 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Michael Panaccio | 27 |
Michael Aicher | 12 |
Neil Gunn | 12 |
Anna Sandham | 9 |
Karl Pechmann | 7 |
Anthony Rule | 7 |
Stephane Chatonsky | 6 |
Caroline Waldron | 6 |
Anthony Radford | 5 |
Pat Noland | 5 |
Phillip Isaacs | 5 |
Peter Manley | 4 |
Robert Birrell | 4 |
John Melki | 3 |
Neralie Coulston | 2 |
- Börse
- Insiders
- Nicholas Samaras
- Unternehmensverbindungen